𝔖 Bobbio Scriptorium
✦   LIBER   ✦

OC7 AN IL28B POLYMORPHISM PREDICTS PEGYLATED INTERFERON PLUS RIBAVIRIN TREATMENT OUTCOME IN CHRONIC HEPATITIS C GENOTYPE 4

✍ Scribed by S. De Nicola; A. Aghemo; M.G. Rumi; E. Galmozzi; L. Valenti; R. Soffredini; R. De Francesco; G.M. Prati; R. D'Ambrosio; C. Cheroni; M.F. Donato; M. Colombo

Book ID
118648070
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
92 KB
Volume
43
Category
Article
ISSN
1590-8658

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Interleukin 28B polymorphism predicts pe
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4
✍ Stella De Nicola; Alessio Aghemo; Maria Grazia Rumi; Enrico Galmozzi; Luca Valen πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 499 KB πŸ‘ 1 views

Single nucleotide polymorphisms (SNPs) near the interleukin 28B (IL28B) region are the strongest baseline predictors of a sustained virologic response (SVR) to peg-interferon (PegIFN) and ribavirin (Rbv) in patients with hepatitis C virus (HCV) genotype 1 infection. Whether this holds true for HCV-4

Pegylated interferon alpha-2b plus ribav
Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues
✍ Ming-Lung Yu; Chia-Yen Dai; Jee-Fu Huang; Ming-Yen Hsieh; Wan-Long Chuang πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 63 KB πŸ‘ 2 views

accurate representation of the data is given in Table 1. 7. The major conclusion of this paper was that monitoring hepatitis C virus RNA levels and varying the duration of therapy can save resources without sacrificing rates of SVR. The authors used the Blackwelder test to test the noninferiority of